Your Web Site
Antyra signs licensing agreement with Novo Nordisk
Nov 13, 2008 (Datamonitor via COMTEX) -- -- Antyra, a biotechnology company, has entered into a global licensing agreement with Novo Nordisk, a healthcare company, for IGF-related antagonists for the treatment of cancer and...

